Literature DB >> 6421579

The 5S RNA binding protein from yeast (Saccharomyces cerevisiae) ribosomes. An RNA binding sequence in the carboxyl-terminal region.

M Yaguchi, C F Rollin, C Roy, R N Nazar.   

Abstract

The carboxyl-terminal half (CN2 fragment) of the yeast 5S RNA binding protein (YL3) retains an ability to form homogeneous ribonucleoprotein complexes with RNA although the N-terminal half (CN1) appears to confer specificity for the 5S RNA molecule [Nazar, R.N., Yaguchi, M., Willick, G.E., Rollin, C.F. and Roy, C. (1979) Eur. J. Biochem. 102, 573-582]. The nucleic acid binding site in this fragment was more clearly delineated by cleaving the CN2 fragment with a variety of enzymatic and chemical reagents and further examining the ability of the products to form RNA-peptide complexes. Hot acetic acid treatment produced a 47-residue subfragment (CN2-A1) which originated from the C terminus and continued to form stable ribonucleopeptide complexes. The amino acid sequence of this subfragment was determined to be: -Pro-Ala-Phe-Lys-Pro-Thr-Glu-Lys50-Phe-Thr-Lys-Glu-Gln-Tyr-Ala-Ala -Glu60-Ser-Ly s -Lys-Tyr-Arg-Gln-Thr-Lys-Leu-Ser70-Lys-Gln-Gln-Arg-Ala-Ala-Arg-Val -Ala-Ala80-Ly s -Ile-Ala-Ala-Leu-Ala-Gly-Gln-Gln-COOH, with 12 of the 16 basic residues in the CN2 fragment being present in this binding site. The amino acid sequence of the CN2-A1 fragment bears a limited homology in both amino acid and charge distribution with histone 2B from mammals and with one of the 5S RNA binding proteins (EL25) from Escherichia coli. The results suggest that many protein binding sites for nucleic acids may share common structural features and further support the notion that the single large eukaryotic 5S RNA protein may have evolved through a fusion of genes for the multiple 5S RNA binding proteins in prokaryotes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421579     DOI: 10.1111/j.1432-1033.1984.tb08026.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Involvement of lysine and arginine residues in the binding of yeast ribosomal protein YL3 to 5S RNA.

Authors:  A Vioque; F Hernández; E Palacián
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

2.  Defining the RNA-protein interactions in the trypanosome preribosomal complex.

Authors:  Lei Wang; Martin Ciganda; Noreen Williams
Journal:  Eukaryot Cell       Date:  2013-02-08

3.  Biological significance of 5S rRNA import into human mitochondria: role of ribosomal protein MRP-L18.

Authors:  Alexandre Smirnov; Nina Entelis; Robert P Martin; Ivan Tarassov
Journal:  Genes Dev       Date:  2011-06-15       Impact factor: 11.361

4.  Developmental expression and 5S rRNA-binding activity of Xenopus laevis ribosomal protein L5.

Authors:  W M Wormington
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Yeast ribosomal proteins: XI. Molecular analysis of two genes encoding YL41, an extremely small and basic ribosomal protein, from Saccharomyces cerevisiae.

Authors:  K Suzuki; T Hashimoto; E Otaka
Journal:  Curr Genet       Date:  1990-03       Impact factor: 3.886

6.  Yeast ribosomal protein L1 is required for the stability of newly synthesized 5S rRNA and the assembly of 60S ribosomal subunits.

Authors:  M Deshmukh; Y F Tsay; A G Paulovich; J L Woolford
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  Electron microscopic visualisation of the 5S rRNA-YL3 complex from Saccharomyces cerevisiae.

Authors:  K M Kyle; G Harauz
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

8.  Functional features of the C-terminal region of yeast ribosomal protein L5.

Authors:  Hossein Moradi; Ivailo Simoff; Galyna Bartish; Odd Nygård
Journal:  Mol Genet Genomics       Date:  2008-08-27       Impact factor: 3.291

9.  A novel association between two trypanosome-specific factors and the conserved L5-5S rRNA complex.

Authors:  Martin Ciganda; Kimberly Prohaska; Kristina Hellman; Noreen Williams
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.